Literature DB >> 33599939

Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Velina Nedkova1, Gerardo Gutiérrez-Gutiérrez2, Francisco J Navacerrada-Barrero2, José Berciano3, Carlos Casasnovas1.   

Abstract

Using recent optimized electrodiagnostic criteria sets, we aimed at verifying the accuracy of initial nerve conduction studies (NCS) in classic very early Guillain-Barré syndrome (VEGBS), ≤ 4 days after onset, compared with the results of serial NCS. This is a retrospective study based on unreported and consecutive VEGBS patients admitted to two university hospitals between 2015 and 2019. Each patient had serial NCS in at least four nerves. Initial NCS studies were done within 4 days after onset, and serial ones from days 20 to 94. Electrophysiological recordings were blinded evaluated by four of the authors, GBS subtype being established accordingly. Seven adult classic VEGBS patients were identified with a median age of 58 years. At first NCS, GBS subtyping was only possible in 1 case that exhibited an axonal pattern, the remaining patterns being equivocal in 3, and mixed (combining axonal and demyelinating criteria) in the remaining 3. Upon serial NSC there was a rather intricate evolution of electrophysiological GBS patterns, 3 of them being classified as axonal or demyelinating, and the remaining 4 as equivocal or mixed. NCS in VEGBS systematically allows detection of changes suggestive of peripheral neuropathy, though even after serial studies accurate GBS subtyping was only possible in 43% of cases. We provide new pathophysiological insights for better understanding of the observed electrophysiological changes.
© 2021. Belgian Neurological Society.

Entities:  

Keywords:  Axonal degeneration; Demyelination; Electrophysiology; Endoneurial inflammatory edema; Guillain-Barré syndrome; Neurofilament light chain; Reversible conduction failure; Very early Guillain-Barré syndrome

Mesh:

Year:  2021        PMID: 33599939     DOI: 10.1007/s13760-021-01603-7

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  45 in total

Review 1.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 2.  The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand?

Authors:  Antonino Uncini; Satoshi Kuwabara
Journal:  Clin Neurophysiol       Date:  2018-10-28       Impact factor: 3.708

Review 3.  Guillain-Barré syndrome.

Authors:  Hugh J Willison; Bart C Jacobs; Pieter A van Doorn
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

4.  Early electrodiagnostic findings in Guillain-Barré syndrome.

Authors:  P H Gordon; A J Wilbourn
Journal:  Arch Neurol       Date:  2001-06

5.  Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis.

Authors:  Antonino Uncini; Luigi Ippoliti; Nortina Shahrizaila; Yukari Sekiguchi; Satoshi Kuwabara
Journal:  Clin Neurophysiol       Date:  2017-04-20       Impact factor: 3.708

Review 6.  Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.

Authors:  Antonino Uncini; Satoshi Kuwabara
Journal:  Clin Neurophysiol       Date:  2012-04-04       Impact factor: 3.708

7.  Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice?

Authors:  Yusuf A Rajabally; Marie-Christine Durand; James Mitchell; David Orlikowski; Guillaume Nicolas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-05-09       Impact factor: 10.154

8.  Pathology of the motor-sensory axonal Guillain-Barré syndrome.

Authors:  J W Griffin; C Y Li; T W Ho; M Tian; C Y Gao; P Xue; B Mishu; D R Cornblath; C Macko; G M McKhann; A K Asbury
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

9.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more
  2 in total

1.  Pathogenic events in very early Guillain-Barré syndrome: neither demyelination nor axonal degeneration but endoneurial inflammatory oedema.

Authors:  José Berciano
Journal:  J Neurol       Date:  2021-09-03       Impact factor: 4.849

2.  Electrodiagnostic subtyping in Guillain-Barré syndrome: Use of criteria in practice based on a survey study in IGOS.

Authors:  Samuel Arends; Judith Drenthen; Peter Y K Van den Bergh; Robert D M Hadden; Nortina Shahrizaila; Mazen M Dimachkie; Gerardo Gutiérrez Gutiérrez; Hans Katzberg; Lynette Kiers; Helmar C Lehmann; Yann Péréon; Ricardo C Reisin; Antonino Uncini; Camiel Verhamme; Wagar Waheed; David R Cornblath; Bart C Jacobs
Journal:  J Peripher Nerv Syst       Date:  2022-06-24       Impact factor: 5.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.